• Bionote will hold an extraordinary shareholders' meeting on Nov. 26, 2026, at the Hwaseong Chamber of Commerce in Hwaseong.
• Shareholders will vote on appointing three independent directors to three-year terms, with all three also nominated for the audit committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionote Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026800155), on October 26, 2026, and is solely responsible for the information contained therein.